Background Patients with acute ST-segment elevation myocardial infarction (STEMI), primary angioplasty is often accompanied with myocardial perfusion bad, no-reflow reperfusion that influences both mortality and progression of heart failure, and also is frequently not available or performed beyond the recommended time limit.We designed a randomized, controlled study to evaluate whether early routine post-fibrinolysis angioplasty represents a reasonable reperfusion option for victims of STEMI irrespective of no reflow mechanism and geographic or logistical barriers.